Skip to content

A Prospective, Non-randomized, Multicenter Study of the Efficacy of Adhesion Barriers in Laparoscopic Surgery for Colorectal Cancer in Japan

A Prospective, Non-randomized, Multicenter Study of the Efficacy of Adhesion Barriers in Laparoscopic Surgery for Colorectal Cancer in Japan - SETOUCHI Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035144
Enrollment
1200
Registered
2018-12-17
Start date
2019-04-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

None listed

Sponsors

Department of Clinical Oncology, Kawasaki Medical School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients who are planned to laparoscopic resection of colorectal cancer. 2) PS: 0 to 2 (ECOG performance status score). 3) Patients who can agree to join this study by written consent. 4) Patients judged to be able to survive for more than 1 year from the date of registration.

Exclusion criteria

Exclusion criteria: 1) History of allergy for adhesion barriers 2) Cancerous ascites or peritoneal dissemination is observed on radiographic image 3) The attending physician deems inappropriate for participation in this study

Design outcomes

Primary

MeasureTime frame
Comparison of Incidence of adhesion-related complications observed in patients without adhesion prevention material with that of patients with adhesion prevention materials.

Secondary

MeasureTime frame
1) incidence of adhesion-related complications between anti-adhesion materials. 2) incidence of adhesion-related complications by adhesion preventing material spraying sites. 3) postoperative recurrence rate, relapse-free survival and overall survival of Stage II / III colorectal cancer after curative resection. 4) incidence of adhesion-related complications, postoperative recurrence rate, relapse-free survival , and overall survival of Stage II / III colorectal cancer after curative resection stratified by somatic mutation in colorectal cancer.

Countries

Japan

Contacts

Public ContactTakeshi Nagasaka

Kawasaki Medical School Hospital Department of Clinical Oncology

takeshin@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026